Ebarle, Hannah Mae .
HRN: 24-08-29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2023
CEFUROXIME 1.5GM (VIAL)
11/13/2023
11/19/2023
IVT
600mg
Q8
Uti, Bfc
Waiting Final Action
Indication: Prophylaxis Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes